| Literature DB >> 32617757 |
Joke Hellinga1, Martin W Stenekes2, Paul M N Werker1, Moniek Janse3, Joke Fleer3, Boudewijn van Etten4.
Abstract
BACKGROUND: Lotus petal flaps (LPF) may be used for the reconstruction of extralevator abdominoperineal defects that cannot be closed primarily. Limited data are available on how perineal reconstruction with the LPF impacts on patients' quality of life (QoL), sexual functioning, and physical functioning.Entities:
Mesh:
Year: 2020 PMID: 32617757 PMCID: PMC7669788 DOI: 10.1245/s10434-020-08771-5
Source DB: PubMed Journal: Ann Surg Oncol ISSN: 1068-9265 Impact factor: 5.344
Study characteristics
| Lotus petal flap group [ | Control group [ | ||
|---|---|---|---|
| Age, years [mean (SD)] | 60.4 (13.6) | 63.7 (9.9) | 0.64 |
| Sex, male | 12 (80.0) | 11 (68.8) | 0.47 |
| Tumor type | 0.17 | ||
| Rectal cancer | 12 (80.0) | 16 (100) | |
| Anal cancer | 2 (13.3) | 0 (0) | |
| Giant condylomata | 1 (6.7) | 0 (0) | |
| Tumor classification | 0.04 | ||
| T1 | 2 (13.3) | 0 (0) | |
| T2 | 3 (20.0) | 8 (50.0) | |
| T3 | 6 (40.0) | 8 (50.0) | |
| T4 | 4 (26.7) | 0 (0) | |
| Excision type | 0.001 | ||
| APE | 0 (0) | 16 (100) | |
| ELAPE | 4 (26.7) | 0 (0) | |
| ELAPE + excision sacrum | 4 (26.7) | 0 (0) | |
| Total exenteration | 4 (26.7) | 0 (0) | |
| Total exenteration + excision sacrum | 2 (13.3) | 0 (0) | |
| Total colectomy + rectal amputation | 1 (6.7) | 0 (0) | |
| Radiotherapy | 15 (100) | 16 (100) | NA |
| Type of (chemo)radiotherapy | 0.01 | ||
| Long-course chemoradiation | 13 (86.7) | 7 (43.8) | |
| Short-course radiotherapy (5 × 5 Gy) | 1 (6.7) | 9 (56.3) | |
| Previous radiotherapy | 1 (6.7) | 0 (0) | |
| Time between surgery and survey, months [median (range)] | 30.6 (16.4–64.3) | 16.1 (13.5–21.2) | <0.001 |
APE abdominoperineal excision, ELAPE extralevator abdominoperineal excision, SD standard deviation, NA statistical analyses could not be performed due to a 100% score in both groups
Data are expressed as n (%) unless otherwise specified
Fig. 1A 55-year-old male patient. (a) Defect following ELAPE; (b) harvest of lotus petal flap; (c) direct post-reconstruction; (d) 11 days post-reconstruction; (e) 10 weeks post-reconstruction; (f) 2 years post-reconstruction. ELAPE extralevator abdominoperineal excision
EORTC QLQ-C30 and EORTC QLQ-CR29 scores
| Lotus petal flap group [ | Control group [ | Reconstruction effect ( | 95% CI | ||||
|---|---|---|---|---|---|---|---|
| Median | Range | Median | Range | ||||
| Global health status | 66.7 | 33.3–100 | 79.2 | 33.3–100 | 8.0 | − 17.0 to 33.0 | 0.51 |
| Functional scales | |||||||
| Physical functioning | 66.7 | 26.7–100 | 80.0 | 0.0–100 | 6.7 | − 19.3 to 32.7 | 0.60 |
| Role functioning | 50.0 | 16.7–100 | 83.3 | 0.0–100 | − 11.5 | − 43.8 to 20.7 | 0.47 |
| Emotional functioning | 75.0 | 25.0–100 | 95.8 | 0.0–100 | 3.7 | − 32.0 to 39.4 | 0.83 |
| Cognitive functioning | 83.3 | 16.7–100 | 83.3 | 16.7–100 | 3.3 | − 29.6 to 36.1 | 0.84 |
| Social functioning | 66.7 | 16.7–100 | 100 | 0.0–100 | − 6.8 | − 44.1 to 30.5 | 0.71 |
| Functional scales | |||||||
| Body image | 33.3 | 0.0–100 | 77.8 | 0.0–100 | − 18.1 | − 61.5 to 25.3 | 0.40 |
| Anxiety | 66.7 | 0.0–100 | 83.3 | 0.0–100 | − 18.3 | − 63.0 to 26.4 | 0.41 |
| Weight | 100 | 0.0–100 | 100 | 0.0–100 | − 6.0 | − 44.9 to 32.9 | 0.76 |
A high score represents a high quality of life or a high level of functioning
CI confidence interval, EORTC QLQ-CR29 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire CR29, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30